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Polarization of Monocytes into M2 Macrophages
Crystal Rocher, Dinender K. Singla*
Biomolecular Science Center, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America
Abstract
Previously we demonstrated that bone morphogenetic protein-7 (BMP-7) treatment polarizes monocytes into M2
macrophages and increases the expression of anti-inflammatory cytokines. Despite these findings, the mechanisms for the
observed BMP-7 induced monocyte polarization into M2 macrophages are completely unknown. In this study, we
demonstrate the mechanisms involved in the polarization of monocytes into M2 macrophages. Apoptotic conditioned
media (ACM) was generated to mimic the stressed conditions, inducing monocyte polarization. Monocytes were treated
with ACM along with BMP-7 and/or its inhibitor, follistatin, for 48 hours. Furthermore, an inhibitor of the PI3K pathway, LY-
294002, was also studied. Our data show that BMP-7 induces polarization of monocytes into M2 macrophages while
significantly increasing the expression of anti-inflammatory markers, arginase-1 and IL-10, and significantly (p,0.05)
decreasing the expression of pro-inflammatory markers iNOS, IL-6, TNF-a and MCP-1; (p,0.05). Moreover, addition of the
PI3K inhibitor, LY-294002, significantly (p,0.05) decreases upregulation of IL-10 and arginase-1, suggesting involvement of
the PI3K pathway in M2 macrophage polarization. Next, following BMP-7 treatment, a significant (p,0.05) increase in p-
SMAD1/5/8 and p-PI3K expression resulting in downstream activation of p-Akt and p-mTOR was observed. Furthermore,
expression of p-PTEN, an inhibitor of the PI3K pathway, was significantly (p,0.05) increased in the ACM group. However,
BMP-7 treatment inhibited its expression, suggesting involvement of the PI3K-Akt-mTOR pathway. In conclusion, we
demonstrate that BMP-7 polarizes monocytes into M2 macrophages and enhances anti-inflammatory cytokine expression
which is mediated by the activated SMAD-PI3K-Akt-mTOR pathway.
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Introduction
Atherosclerosis, an inflammatory disease that results in hard-
ening and narrowing of large and small arteries due to plaque
formation, is the leading cause of myocardial infarction and stroke
and affects millions of people every year [1–4]. Previous data
suggest that the inflammatory response that occurs during
atherosclerosis development can determine the severity of the
disease and its progression [4]. During inflammation, monocytes
migrate to the injured area and differentiate into macrophages
[1,2]. Within a pathological environment, the role of macrophages
is multi-faceted and complex and plays a central role to the
physiology of the disease.
There are two main categories of macrophages known as
classical M1 macrophages and alternative M2 macrophages [1,5].
Classical M1 macrophages are pro-inflammatory and secrete such
factors as iNOS, IL-6, TNF-a, and MCP-1, which can enhance
the inflammatory response and result in disease progression.
Conversely, alternative M2 macrophages are anti-inflammatory
and secrete factors such as IL-10 and arginase-1 [5–7]. Specifi-
cally, published data have suggested M2 macrophages promote
tissue repair and wound healing [1,5]. To this end, identification
of mechanisms used to direct the ratio of M1 and M2
macrophages toward a greater percentage of M2 macrophages
following monocyte polarization may offer novel, potential
treatment options for patients suffering from inflammatory
diseases such as atherosclerosis.
Bone morphogenetic protein-7 (BMP-7), a signaling molecule
belonging to the transforming growth factor beta (TGF-b)
superfamily, works through activation of BMPR2, which results
in phosphorylation of R-SMAD1/5/8 and activation of down-
stream mediators in the SMAD pathway. Evidence provided
suggest this occurs in chondrocytes, mesenchymal stem cells and
kidney cells as well as disease models such as osteoarthritis,
diabetic nephropathy and renal injury [8–10]. However, the
mechanisms of BMP-7-induced monocyte polarization into M2
macrophages remain unknown. Therefore, we hypothesized that
following BMP-7 treatment, M2 macrophage polarization occurs
due to the activation of the PI3K-Akt-mTOR pathway. In the
present study, our data demonstrate that following treatment with
BMP-7, expression of p-SMAD1/5/8 significantly increased
resulting in increased expression and activation of p-PI3K.
Furthermore, we identified that activation of PI3K lead to
downstream activation of p-Akt and p-mTOR, following the
initiation of the PI3K-Akt-mTOR pathway. Follistatin, a BMP-7
inhibitor, significantly reduced M2 macrophage polarization as
well as PI3K-Akt-mTOR pathway suggesting its role in polariza-
tion. Additionally, LY-294002, an inhibitor of the PI3K pathway,
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was studied and corroborated the effects of BMP-7 on M2
macrophage polarization through the examination of M2 macro-
phage released anti-inflammatory cytokines, IL-10 and arginase-1.
Materials and Methods
In-vitro cell culture model
As per manufacturer’s instructions, human monocytes (THP-1
cells) purchased from ATCC, were grown in 25 cm2 flasks and
cultured every other day in RPMI 1640 (ATCC) supplemented
with 10% fetal bovine serum and 0.05 mM b-mercaptoethanol
[5].
Stress induced injury model
Apoptotic conditioned media (ACM) was generated and cell
concentration used for monocytes was previously reported by us
[5,11]. In brief, 60 mm tissue culture dishes were each plated with
56105 H9c2 cardiomyoblasts for 24 hours. The cells were then
treated with 400 uM H2O2 for 2 hours. Following treatment,
media was collected, filtered, labeled ACM, and stored for future
use.
Monocyte polarization treatment
Monocytes were divided into the following groups: Control
(monocytes cultured in normal media), ACM (monocytes cultured
in normal media + ACM (40% v/v)), ACM+BMP7 (monocytes
cultured in normal media + ACM (40% v/v) +660 ng/ml BMP-7),
and ACM+BMP7+Follistatin (Foll) (monocytes cultured in normal
media + ACM (40% v/v) + 660 ng/ml BMP-7+500 ng/ml Foll).
Experimental conditions and mouse BMP-7 (Bioclone, San Diego,
CA) and follistatin (Sino Biological, Beijing, China) concentrations
were used as previously reported by us [5]. Briefly, monocytes
were initially plated in a 24 well plate with 40,000 cells per well for
24 hours for stabilization. The cells were then treated based on the
aforementioned groups for an additional 48 hours.
LY-294002 treatment
The PI3K inhibitor, LY-294002, was used as previously
reported [12]. The monocytes were divided into the following
groups: Control (monocytes cultured in normal media), ACM
(monocytes cultured in normal media + ACM (40% v/v)),
ACM+BMP7 (monocytes cultured in normal media + ACM
(40% v/v) + 660 ng/ml BMP-7), and ACM+BMP7+LY) (mono-
cytes cultured in normal media + ACM (40% v/v) +660 ng/ml
BMP27+40 mM LY). As stated above, the monocytes were plated
in a 24 well plate with 40,000 cells per well for 24 hours. Then, the
cells were treated according to the above groups for 48 hours and
next used for experimental analysis.
Immunohistochemistry of BMPR2 and macrophage
markers
As previously reported, cells were removed from the 24 well
plate, centrifuged and used to make smears on ColorFrost Plus
glass slides [5]. The smears were fixed with 4% paraformaldehyde
and blocked with either 10% normal goat serum or normal donkey
serum (Vector Labs) for one hour at room temperature. Following
blocking, the smears were incubated with primary antibodies for
either anti-CD14, anti-iNOS, anti-CD206, anti-arginase-1, or
anti-BMPR2 overnight at 4uC. Next, appropriate secondary
antibodies, goat anti-rabbit Alexa 568 or donkey anti-goat Alexa
488, were added for 1 hour at room temperature. Finally, the
smears were stained with DAPI (49, 6-diamidino-2-phenylindole)
(Vector Labs) and cover-slipped. The slides were analyzed under
an Olympus fluorescent microscope.
Pro and anti-inflammatory cytokine ELISAs
ELISA kits were purchased from Raybiotech and used to
quantify anti-inflammatory (IL-10) and pro-inflammatory (IL-6,
TNF-a, and MCP-1) cytokine expression. Following treatment,
the culture media was isolated from each group, centrifuged, and
the supernatant collected. The supernatant was then added to pre-
coated strips and the ELISAs were performed as per manufactur-
er’s instructions and as previously reported [5].
Western blot analysis
Western blot was performed as previously reported [12]. In
brief, cells were collected, centrifuged, and lysed on ice for 30
minutes in RIPA buffer supplemented with protease inhibitor
cocktail, PMSF, sodium orthovanadate and sodium fluoride.
Protein concentration was estimated for each cell lysate using the
Bio-Rad protein assay and read on a microplate reader at 595 nm.
Following protein concentration determination, 100 mg of the
prepared protein samples were loaded and run on an 8 or 10%
sodium-dodecyl sulfate polyacrylamide gel at 150 V for 60 to 80
minutes depending on the molecular weight of the proteins to be
separated. Next, proteins were transferred onto a PVDF mem-
brane (Bio-Rad) which was then blocked with 5% milk and
incubated with the primary antibodies p-SMAD1/5/8 (Cell
Signaling, 1:1000), p-PI3K (Cell Signaling, 1:1000), Total PI3K
(Cell Signaling, 1:1000), p-Akt (Cell Signaling, 1:1000), p-PTEN
(Cell Signaling, 1:1000), p-mTOR (Cell Signaling, 1:1000) or
Total mTOR (Cell Signaling, 1:1000). Following primary
antibody incubation, membranes were washed, incubated with
secondary antibody anti-rabbit IgG (Cell Signaling, 1:1000), and
then exposed with a Visualizer. Densitometry analysis was
completed with the help of Image J software which allows for
the quantification of band intensity. Developed films were scanned
and opened using Image J software. A rectangle was placed on
each band and the band intensity was analyzed as well as the
background intensity. Quantification was determined by subtract-
ing band intensity with background intensity. Protein expression
was corrected with a loading control such as b-actin, total mTOR
or total PI3K and this by dividing the protein densitometry value
by its control. All western blot data is presented as: Protein
densitometry/control protein densitometry.
Statistical analysis
Data was analyzed using One-way analysis of variance
(ANOVA) followed by the Tukey Test. Data is presented as a
mean 6 SEM and statistical significance assigned when p-value
,0.05.
Results
Expression of BMPR2 increases following treatment with
BMP-7 on monocytes
Representative photomicrographs shown in Figure 1A demon-
strate BMP-7 receptors (BMPR2) in green (a, f, k, p), CD14
positive monocytes in red (b, g, l, q), total nuclei stained blue (c, h,
m, r), merged images of cells positive for BMPR2, CD14 and
DAPI (d, i, n, s) and enlarged merged images (e, j, o, t).
Quantitative analysis reveals that following treatment with BMP-7,
monocytic BMPR2 expression is significantly enhanced compared
to the control and ACM groups (Figure 1B). Additionally, BMPR2
expression was significantly inhibited in the ACM+BMP7+Foll
group compared to the ACM+BMP7 groups suggesting follistatin
Monocyte Polarization into M2 Macrophages
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e84009
blocks BMPR2 upregulation through inhibition of normal BMP-7
mediation.
Expression of BMPR2 increases following treatment with
BMP-7 on M2 macrophages
Figure 2A is representative images of cells positive for BMPR2
in green (a, f, k, p), CD206 (an M2 macrophage marker) in red (b,
g, l, q), total nuclei in blue (c, h, m, r), merged images (d, i, n, s) and
enlarged merged images (e, j, o, t). BMPR2 expression was
significantly enhanced on polarized M2 macrophages in the
ACM+BMP7 groups relative to control and ACM groups
(Figure 2B). However, a significant reduction in BMPR2
expression on M2 macrophages was observed in the
ACM+BMP7+Foll group compared with the ACM+BMP7 group
(figure 2B).
Treatment with BMP-7 decreases expression of pro-
inflammatory markers
Representative photomicrographs shown in Figure 3A demon-
strate iNOS positive M1 macrophages in red (a, e, i, m), total
nuclei in blue (b, f, j, n), merged images in pink (c, g, k, o), and
enlarged merged images (d, h, l, p) for all control and experimental
groups. iNOS positive M1 macrophage concentrations were
significantly enhanced in the ACM and ACM+BMP7+Foll groups
compared to control (Figure 3B). However, the number of M1
macrophages was significantly decreased in the BMP-7 treated
group relative to the ACM treated group (Figure 3B). Additionally,
compared with the ACM+BMP7 treatment group, M1 macro-
phages were significantly enhanced in the ACM+BMP7+Foll
group (Figure 3B) suggesting BMP-7 prevents monocyte to M1
macrophage polarization.
Quantitative analysis of pro-inflammatory cytokine data
including IL-6, TNF-a and MCP-1 is represented in Figures 3C,
D and E, respectively. Data suggest a significant increase in IL-6,
TNF-a and MCP-1 expression in the ACM group compared with
control (Figure 3C, D, and E). However, this increased concen-
tration of pro-inflammatory cytokines was significantly abolished
following BMP-7 treatment (Figure 3C, D, and E). Moreover,
follistatin treatment resulted in significantly increased expression of
IL-6, TNF-a and MCP-1 (Figure 3C, D, and E).
Anti-inflammatory expression increases following
treatment with BMP-7
Representative photomicrographs demonstrating CD206 posi-
tive M2 macrophages in red (a, e, i, m), total nuclei stained blue (b,
f, j, n), merged images in pink (c, g, k, o), and enlarged merged
images (d, h, l, p) are depicted in Figure 4A. Corresponding
quantitative analysis of the percentage of cells positive for the M2
macrophage marker, CD206, reveal a significant increase in the
number of M2 macrophages in the ACM+BMP7 group compared
to control and ACM groups (Figure 4B). However, the number of
M2 macrophages was significantly decreased in the
ACM+BMP7+Foll group relative to the ACM+BMP7 group
(Figure 4B).
Anti-inflammatory signaling molecules including arginase-1 and
IL-10 were also assessed. Following treatment with BMP-7, a
significant increase in the percentage of cells positive for arginase-1
was observed (Figure 4C). However, following follistatin treatment,
a significant decreased was detected in the percentage of arginase-
1 positive cells compared to the ACM+BMP7 group (Figure 4C).
Additionally, levels of IL-10 were significantly increased in the
ACM+BMP7 group compared to the control and ACM groups
(Figure 4D). Conversely, treatment with follistatin abrogated the
increased IL-10 expression following BMP-7 treatment
(Figure 4D). Collectively, our data suggest BMP-7 promotes M2
macrophage polarization and anti-inflammatory expression.
Treatment with LY-294002 inhibits the BMP-7 induced
increase in IL-10 and arginase-1
In order to further confirm the role of BMP-7 on M2
macrophage anti-inflammatory cytokine expression through acti-
vation of the PI3K pathway, an inhibitor of the PI3K pathway,
was used. Figure 5A shows quantitative expression of anti-
inflammatory cytokine, IL-10. Following treatment, levels of IL-
10 remained the same between the Control and ACM groups;
however, they were significantly increased in the ACM+BMP7
Figure 1. Treatment with BMP-7 increases expression of BMPR2 on monocytes. Left panel A shows representative photomicrographs of
anti-BMPR2 in green (a, f, k, p), anti-CD14 in red (b, g, l, q), DAPI in blue (c, h, m, r), merged images (d, i, n, s) and enlarged merged images (e, j, o, t).
Scale bar = 50 mm. Right histogram B shows quantitative analysis of CD14 positive cells expressing BMPR2 with a significant increase in the
ACM+BMP7 group compared to Control, ACM and ACM+BMP7+Foll groups. *p,0.05 vs Control, #p,0.05 vs ACM, $p,0.05 vs ACM+BMP7, n = 6.
doi:10.1371/journal.pone.0084009.g001
Monocyte Polarization into M2 Macrophages
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group compared to the control and ACM groups (Figure 5A).
When treated with LY the increased IL-10 expression significantly
decreased compared to the ACM+BMP7 group (Figure 5A).
Furthermore, the percentage of arginase-1 positive cells was also
examined. Figure 5B shows that there is no significant increase in
percentage of positive cells in the Control and ACM group, but
when treated with BMP-7, the percentage significantly increased.
However, following LY treatment, the percentage of arginase-1
positive cells significantly decreased compared to the ACM+BMP7
group (Figure 5B). This data suggests that treatment with a PI3K
inhibitor such as LY decreases expression of anti-inflammatory
cytokines which are released by M2 macrophages. Therefore, we
Figure 2. Expression of BMPR2 is increased in M2 macrophages following treatment with BMP-7. Left panel A shows representative
photomicrographs of anti-BMPR2 in green (a, f, k, p), anti-CD206 in red (b, g, l, q), DAPI in blue (c, h, m, r), merged images (d, i, n, s), and enlarged
merged images (e, j, o, t). Scale bar = 50 mm. Right histogram B shows quantitative analysis of CD206 positive cells expressing BMPR2 with a
significant increase in the ACM+BMP7 group compared to Control, ACM and ACM+BMP7+Foll groups. *p,0.05 vs Control, #p,0.05 vs ACM,
$p,0.05 vs ACM+BMP7, n = 5–6.
doi:10.1371/journal.pone.0084009.g002
Figure 3. Treatment with BMP-7 decreases expression of M1 macrophage marker, iNOS, as well as pro-inflammatory cytokines. Left
panel A shows representative photomicrographs of anti-iNOS in red (a, e, i, m), DAPI in blue (b, f, j, n), merged images (c, g, k, o) and enlarged merged
images (d, h, l, p). Scale bar = 50 mm. Histogram B shows quantitative analysis of the percentage of cells expressing iNOS with a significant decrease
in the control and ACM+BMP7 and groups and a significant increase in the ACM and ACM+BMP7+Foll groups; n = 5–6. Histogram C shows
quantitative analysis of expression of IL-6 with a significant decrease in the ACM+BMP7 group; n = 5–6. Histogram D shows quantitative analysis of
expression of TNF-a with also a significant decrease in the ACM+BMP7 group; n = 4–6. Histogram E shows quantitative analysis of MCP-1 with also a
significant decrease in the ACM+BMP7 group; n = 5–7. *p,0.05 vs Control, #p,0.05 vs ACM, $p,0.05 vs ACM+BMP7.
doi:10.1371/journal.pone.0084009.g003
Monocyte Polarization into M2 Macrophages
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interpret that a decrease in these anti-inflammatory cytokines will
also affect M2 macrophage polarization, which maybe mediated
by the PI3K pathway.
BMP-7 promotes activation of SMAD1/5/8 and PI3K
To elucidate mechanisms by which BMP-7 promotes M2
macrophage polarization, mediators of BMP signaling were
investigated. Figure 6A, top panel, depicts representative activated
Smad1/5/8, downstream effectors of BMP signaling, and
corresponding control b-actin blots. Quantitative analysis suggests
a significant decrease in activated Smad1/5/8 expression in the
ACM group (Figure 6A). Following BMP-7 treatment, phosphor-
ylated Smad1/5/8 (p-Smad1/5/8) expression dramatically in-
creased which was abolished following treatment with follistatin
(Figure 6A).
Representative blots of phosphorylated phosphoinositide 3-
kinase (p-PI3K), a enzymatic signaling molecule responsible for
promoting cell proliferation, differentiation, and survival, and total
PI3K are shown in the top panels of Figure 6B. Activated PI3K
expression was significantly decreased in the ACM group
Figure 4. Following treatment with BMP-7 polarization of monocytes into M2 macrophages increases as well as expression of anti-
inflammatory markers. Left panel A shows representative photomicrographs of anti-CD206 in red (a, e, i, m), DAPI in blue (b, f, j, n), merged
images (c, g, k, o) and enlarged merged images (d, h, l, p). Scale bar = 50 mm. Histogram B shows quantitative analysis of the percentage of cells
expressing CD206 with a significant increase in the ACM+BMP7 group and a significant decrease in the ACM and ACM+BMP7+Foll groups; n = 5–6.
Histogram C shows quantitative analysis of the percentage of cells expressing Arginase-1 with a significant increase in the ACM+BMP7 group; n = 5–6.
Histogram D shows quantitative analysis of the expression of anti-inflammatory cytokine, IL-10, with a significant increase in the ACM+BMP7 group;
n = 5–6. *p,0.05 vs Control, #p,0.05 vs ACM, $p,0.05 vs ACM+BMP7.
doi:10.1371/journal.pone.0084009.g004
Figure 5. Treatment with LY-294002 decreases expression of anti-inflammatory cytokines. Histogram A shows quantitative analysis of
the expression of anti-inflammatory cytokine, IL-10, with a significant increase in the ACM+BMP7 group; n = 5–6. Histogram B shows quantitative
analysis of the percentage of cells expressing Arginase-1 with a significant increase in the ACM+BMP7 group; n = 5. *p,0.05 vs Control, #p,0.05 vs
ACM, $p,0.05 vs ACM+BMP7.
doi:10.1371/journal.pone.0084009.g005
Monocyte Polarization into M2 Macrophages
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compared to control whereas p-PI3K expression was significantly
increased following BMP-7 treatment (Figure 6B). However,
activated PI3K was significantly decreased in the ACM+BMP7+-
Foll group compared to the ACM+BMP7 group (Figure 6B).
Downstream activation of Akt and mTOR occur following
BMP-7 treatment
Downstream mediators of the PI3K pathway were investigated
to discern mechanisms of PI3K pathway augmentation via BMP-
7. Figure 7A-C, top panels, show representative blots of
phosphorylated Akt (p-Akt), phosphatase and tensin homolog (p-
PTEN), and mammalian target of rapamycin (p-mTOR), respec-
tively. Activated Akt was significantly enhanced in the
ACM+BMP7 group whereas a significant decrease in p-Akt
expression was noted in the ACM+BMP7+Foll group (Figure 7A).
PTEN, an inhibitor of PI3K and subsequent Akt activation, was
significantly upregulated in the ACM ad ACM+BMP7+Foll
groups compared to the control group (Figure 7B). However,
treatment with BMP7 inhibited PTEN activation significantly
(Figure 7B). Finally, densitometric analysis of p-mTOR over total
mTOR expression revealed a significant increase in expression in
the ACM+BMP7 group compared to ACM which was abolished
following follistatin treatment (Figure 7C).
Discussion
Atherosclerosis, an inflammatory disease leading to arterial wall
thickening consequent to plaque formation and accumulation, is
the leading cause of myocardial infarction and stroke [4].
Monocytes play an elemental role in the development and
progression of inflammatory diseases in that they migrate to
damaged areas, divide and differentiate into macrophages.
Monocyte differentiation has the potential to yield pro-inflamma-
tory M1 macrophages or anti-inflammatory M2 macrophages.
Data provided has suggested the ratio of M1 to M2 macrophages
following monocyte polarization can determine the severity and
progression of inflammatory disorders [1,2,13]. Deciphering the
role and mechanisms of monocyte polarization during inflamma-
tion has recently gained the attention of the research community.
Identification of novel growth factors/molecules used to direct
monocyte differentiation and pathways by which this occurs may
provide novel therapeutic options for patients with inflammatory
diseases such as atherosclerosis.
Bone morphogenic proteins (BMPs) are growth factors, which
constitute the largest subset of molecules belonging to the TGF-b
superfamily. Signal transduction mechanisms promoted by BMPs
occur through activation and oligomerization of BMP receptors
(BMPRs) inducing phosphorylation of Smad 1/5/8 and Smad-
independent signaling cascades resulting in transcriptional regu-
lation of target genes. Moreover, there are different isoforms of
BMPs and the role played by these different BMPs varies from
apoptosis, to proliferation, to differentiation [14]. For example,
BMP-2 has been shown to induce cardiomyocyte differentiation
[14]. Therefore, this is a wide area of research that needs to be
further explored in order to determine the effects of different
BMPs on Smad and/or PI3K pathway activation and subsequent
M2 macrophage polarization. Recently reported, BMP-7 was
identified as a novel mediator of monocyte polarization into M2
macrophages [5]. However, the signaling pathway by which BMP-
7 promotes M2 macrophage polarization remains obscure. To this
end, the current study was undertaken to identify mediators of
BMP-7 induced monocyte differentiation and propose a mecha-
nism by which M2 macrophage polarization occurs.
The BMPR2 receptor is directly involved in the BMP-7 ligand
induced oligomerization and subsequent signal transduction
activity. Under normal and stressed conditions induced by
ACM, BMPR2 expression remained unchanged on monocytes
and M2 macrophages as evidenced by co-localization of BMPR2/
CD14 and BMPR2/CD206, respectively. However, exogenous
BMP-7 application resulted in a significant increase in BMPR2
expression on monocytes and M2 macrophages suggesting an
increase in BMP-7 signal transduction activity. Several studies
have supplied supporting evidence to the current findings
indicating an upregulation of BMPR2 expression at 2 days
following BMP-7 administration in various models including
TNBS-induced colitis [5,15]. Of note, following treatment with
follistatin, an inhibitor of BMP-7 signal transduction, significant
upregulation of BMPR2 on monocytes and M2 macrophages was
Figure 6. Binding of BMP-7 to BMPR2 phosphorylates R-SMAD1/5/8 which activates PI3K. Representative western blot bands (A) are
shown of p-SMAD1/5/8 and b-actin with densitometric analysis of P-SMAD1/5/8 showing a significant increase of expression in the ACM+BMP7 group
and a significant decrease of expression in the ACM and ACM+BMP7+Foll groups. Representative western blot bands (B) are shown of p-PI3k and
total PI3K with densitometric analysis of p-PI3K showing a significant increase of expression in the ACM+BMP7 group and a significant decrease of
expression in the ACM and ACM+BMP7+Foll groups. *p,0.05 vs Control, #p,0.05 vs ACM, $p,0.05 vs ACM+BMP7, n = 5-7.
doi:10.1371/journal.pone.0084009.g006
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abolished suggesting a direct relation between BMP-7 signaling
and upregulation of BMPR2.
A determinant of pathology progression is dependent on
macrophage type yields during monocyte differentiation
[1,2,4,13,16]. To this end, M1 macrophage polarization was
investigated as well as concentrations of pro-inflammatory
cytokines. Treatment with ACM and ACM plus follistatin induced
monocyte polarization towards the M1 phenotype, whereas
treatment with BMP-7 dramatically decreased M1 macrophage
yields suggesting the potential of BMP-7 to prevent monocyte to
M1 macrophage polarization. Congruent with increased M1
macrophage concentrations, pro-inflammatory cytokines, IL-6,
TNF-a and MCP-1 were significantly increased in the ACM and
follistatin groups. Conversely, following BMP-7 administration,
concentrations of IL-6, TNF-a and MCP-1 were significantly
reduced suggesting a correlation between BMP-7, diminished M1
macrophage polarization, and reduced pro-inflammatory cytokine
expression.
Equally important, quantification of anti-inflammatory M2
macrophage polarization revealed a significant higher yield of M2
macrophages following BMP-7 treatment and this increase was
adversely augmented following treatment with follistatin. Further-
more, in agreement with M2 macrophage yields, anti-inflamma-
tory markers, arginase-1 and IL-10 were significantly increased
following treatment with BMP-7. Data presented suggest, in the
presence of BMP-7, monocytes are more readily polarizing into
M2 macrophages and expressing anti-inflammatory cytokines but
inhibition of BMP-7 by its inhibitor, follistatin, prevents that
polarization as well as the enhanced expression of anti-inflamma-
tory cytokines. Our data is in accordance with previous reports
demonstrating that, under pathological stressed conditions,
monocytes, which exhibit high plasticity, will undergo polarization
into macrophages and treatment with certain factors can direct
polarization and increase the ratio of M2 macrophages over M1
macrophages [1,4,5,17,18]. By increasing polarization of M2
macrophages from monocytes and thereby increasing expression
of anti-inflammatory markers, the beneficial potential of BMP-7
may include decreasing the progression of the inflammatory
response and preventing further injury.
BMP-7 is known to activate the SMAD1/5/8 pathway
following binding to BMPR2 but studies have shown that it is
also responsible for activation of other non-SMAD pathways such
as the PI3K-Akt-mTOR pathway [3,8,19]. For example, in
granulosa cells, BMP-7 was observed to activate the PI3K pathway
resulting in cell survival [3]. Moreover, activation of the PI3K
pathway through BMP-7 was also shown in THP-1 cells resulting
in increased chemotaxis [19]. Although a correlation between the
SMAD1/5/8 and PI3K pathway has been suggested, the
importance of these pathways with regards to M2 macrophage
polarization following monocyte treatment with BMP-7, has never
been reported.
In the present study, our data suggest that BMP-7 upregulates
and binds BMPR2, phosphorylates SMAD1/5/8, and activates
PI3K, which results in downstream activation of Akt and mTOR
as shown in Figure 8. Additional evidence provided demonstrates
expression of p-PTEN, an inhibitor of the PI3K pathway, was
significantly upregulated in the ACM and ACM+BMP7+Foll
groups but was significantly downregulated following BMP-7
treatment suggesting the ability of BMP-7 to not only promote
PI3K signaling through upregulated mediators but also by directly
blocking inhibition of the signaling cascade [20]. Furthermore, the
inhibitor of BMP-7, follistatin, successfully prevented increased p-
SMAD1/5/8 expression and significantly decreased expression of
PI3K, which is in accordance with previous reports on the role of
follistatin as an inhibitor to BMP-7 [21,22]. Such evidence
supports and suggests the necessity of BMP-7 to bind BMPR2 thus
activating SMAD1/5/8 and subsequently PI3K.
Activation of the PI3K pathway controls production of
transcriptional factors which regulate key inflammatory cytokines
resulting in increased expression of anti-inflammatory markers
Figure 7. Activation of PI3K results in phosphorylation of Akt and mTOR and inhibition of the pathway occurs via PTEN.
Representative western blot bands (A) are shown of p-Akt and b-actin as well as densitometric analysis with a significant increase of expression in the
ACM+BMP7 group and a significant decrease of expression in the ACM+BMP7+Foll group. Next, representative western blot bands (B) are shown of
p-PTEN and b-actin with densitometric analysis showing significant decrease of expression in the ACM+BMP7 group and a significant increase of
expression in the ACM and ACM+BMP7+Foll groups. Lastly, representative western blot bands (C) are shown of p-mTOR and total mTOR with
densitometric analysis showing a significant increase of expression in the ACM+BMP7 group and a significant decrease of expression in the
ACM+BMP7+Foll groups. *p,0.05 vs Control, #p,0.05 vs ACM, $p,0.05 vs ACM+BMP7, n = 5–7.
doi:10.1371/journal.pone.0084009.g007
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such as arginase-1 and IL-10 and inhibition of the production of
pro-inflammatory markers [20,23–25]. Specifically, in bone
marrow derived macrophages, activation of the PI3K pathway
resulted in increased polarization of M2 macrophages [26].
Studies have also shown that inhibition of either PI3K or mTOR
result in M1 macrophage polarization demonstrating the impor-
tance of this pathway in the polarization of monocytes [23,26]. We
suggest that activation of the signaling pathway portrayed in
Figure 8 following BMP-7 administration resulted in increased
expression of anti-inflammatory cytokines and inhibited expression
of pro-inflammatory cytokines, which promoted paracrine effects
on monocytes and macrophages yielding increased M2 macro-
phage polarization.
Moreover, an inhibitor for the PI3K pathway was also
examined in the present study to confirm the role of this pathway
on M2 macrophage polarization and the release of anti-
inflammatory cytokines. BMP-7 treatment significantly increased
expression of IL-10 and percentage of arginase-1 positive cells.
Interestingly, treatment with LY significantly decreased these
levels, suggesting that BMP-7 induced M2 macrophage polariza-
tion and the release of anti-inflammatory cytokines are mediated
by the PI3K pathway.
Within the present study, we are the first to show, as to the best
of our knowledge, the effects of BMP-7 on monocyte polarization
and the contributing mechanisms. Collectively, data presented has
shown that BMP-7 plays a role in monocyte polarization and can
induce M2 macrophage polarization as well as increase expression
of anti-inflammatory cytokines. Furthermore, we suggest that
mechanisms promoting monocyte polarization following BMP-7
treatment involve activation of the PI3K-Akt-mTOR pathway. In
this study, we focused on the effects of BMP-7 on monocyte
polarization following 48 hours of treatment, however, further
studies will need to be performed involving other time points to
fully understand the effects of BMP-7 on PI3K signaling and
monocyte polarization.
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